Ablacon Company

Ablacon is a provider of AI-guided atrial fibrillation therapies.

Total Funding: $6.8B
Headquarters: Wheat Ridge, Colorado, United States
Estimated Revenue: $50M to $100M
Last Funding Type: Post-IPO Equity
Technology: ['BioTech & HealthTech']
Investor Type: contact@ablacon.com
Investors Number: 7
Founded Date: 2015
Industry: Med Tech